Australia Temporal Arteritis Market (2025-2031) | Value, Analysis, Trends, Size & Revenue, Companies, Outlook, Forecast, Segmentation, Share, Industry, Growth, Competitive Landscape

Market Forecast By Treatment (Corticosteroids, Aristocort, Bubbli-Pred, Immunosuppressive Agents, Adalimumab, Infliximab, Anticoagulants), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) And Competitive Landscape
Product Code: ETC6192659 Publication Date: Sep 2024 Updated Date: May 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Australia Temporal Arteritis Market Overview

Temporal arteritis, also known as giant cell arteritis, is an inflammatory condition affecting the blood vessels, often leading to vision loss if untreated. The Australia temporal arteritis market is driven by the aging population, as the condition predominantly affects individuals over the age of 50. Treatments for temporal arteritis typically involve corticosteroids, and there is increasing interest in the development of new, more targeted therapies to prevent complications. The growing awareness of this condition and the advancement of diagnostic techniques are expected to contribute to the market’s expansion in the coming years.

Trends of the market

The temporal arteritis market in Australia is driven by an aging population, as this condition primarily affects individuals over 50 years of age. Temporal arteritis is characterized by inflammation of the arteries in the head, leading to headaches, vision problems, and even stroke in severe cases. The treatment market for this condition includes corticosteroids as the primary therapy, with new therapies such as biologic drugs also emerging as potential options. As the awareness of temporal arteritis grows, especially among healthcare professionals, the demand for effective treatments is expected to rise, alongside improved diagnostic tools that enable early detection of this potentially debilitating condition.

Challenges of the market

The Temporal Arteritis Market in Australia faces the challenge of underdiagnosis, as the condition often goes unnoticed or is mistaken for other common ailments. As a result, many individuals experience delayed treatment, leading to more severe complications. Furthermore, there is limited awareness about this condition among the general population, leading to lower demand for specialized treatments. The cost of treatments, especially for those requiring long-term medication or surgical interventions, is another challenge that limits access for some patients.

Investment opportunities in the Market

While a niche segment, the temporal arteritis market presents investment opportunities in early diagnosis and treatment technologies, including imaging tools, biomarkers, and targeted drug development. As the condition primarily affects older adults, there`s potential for integrated care solutions combining diagnostics, pharmaceuticals, and long-term monitoring systems that can attract healthcare and biotech investors.

Government Policy of the market

Temporal arteritis treatment in Australia falls under the broader healthcare policy framework, particularly Medicare and the PBS, which subsidize diagnostic tests and immunosuppressive medications. The TGA governs the safety and distribution of corticosteroids and related drugs used in treatment. Policies promoting early diagnosis of autoimmune conditions also support increased screening and awareness among general practitioners and rheumatologists.

Key Highlights of the Report:

  • Australia Temporal Arteritis Market Outlook
  • Market Size of Australia Temporal Arteritis Market, 2024
  • Forecast of Australia Temporal Arteritis Market, 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Revenues & Volume for the Period 2021- 2031
  • Australia Temporal Arteritis Market Trend Evolution
  • Australia Temporal Arteritis Market Drivers and Challenges
  • Australia Temporal Arteritis Price Trends
  • Australia Temporal Arteritis Porter's Five Forces
  • Australia Temporal Arteritis Industry Life Cycle
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Corticosteroids for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Aristocort for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Bubbli-Pred for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Immunosuppressive Agents for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Adalimumab for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Infliximab for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Anticoagulants for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of Australia Temporal Arteritis Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Australia Temporal Arteritis Import Export Trade Statistics
  • Market Opportunity Assessment By Treatment
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End User
  • Market Opportunity Assessment By Distribution Channel
  • Australia Temporal Arteritis Top Companies Market Share
  • Australia Temporal Arteritis Competitive Benchmarking By Technical and Operational Parameters
  • Australia Temporal Arteritis Company Profiles
  • Australia Temporal Arteritis Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Australia Temporal Arteritis Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Australia Temporal Arteritis Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Temporal Arteritis Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Temporal Arteritis Market Revenues & Volume, 2021 & 2031F

3.3 Australia Temporal Arteritis Market - Industry Life Cycle

3.4 Australia Temporal Arteritis Market - Porter's Five Forces

3.5 Australia Temporal Arteritis Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.6 Australia Temporal Arteritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Australia Temporal Arteritis Market Revenues & Volume Share, By End User, 2021 & 2031F

3.8 Australia Temporal Arteritis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 Australia Temporal Arteritis Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Australia Temporal Arteritis Market Trends

6 Australia Temporal Arteritis Market, By Types

6.1 Australia Temporal Arteritis Market, By Treatment

6.1.1 Overview and Analysis

6.1.2 Australia Temporal Arteritis Market Revenues & Volume, By Treatment, 2021- 2031F

6.1.3 Australia Temporal Arteritis Market Revenues & Volume, By Corticosteroids, 2021- 2031F

6.1.4 Australia Temporal Arteritis Market Revenues & Volume, By Aristocort, 2021- 2031F

6.1.5 Australia Temporal Arteritis Market Revenues & Volume, By Bubbli-Pred, 2021- 2031F

6.1.6 Australia Temporal Arteritis Market Revenues & Volume, By Immunosuppressive Agents, 2021- 2031F

6.1.7 Australia Temporal Arteritis Market Revenues & Volume, By Adalimumab, 2021- 2031F

6.1.8 Australia Temporal Arteritis Market Revenues & Volume, By Infliximab, 2021- 2031F

6.2 Australia Temporal Arteritis Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Australia Temporal Arteritis Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 Australia Temporal Arteritis Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3 Australia Temporal Arteritis Market, By End User

6.3.1 Overview and Analysis

6.3.2 Australia Temporal Arteritis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 Australia Temporal Arteritis Market Revenues & Volume, By Homecare, 2021- 2031F

6.3.4 Australia Temporal Arteritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.3.5 Australia Temporal Arteritis Market Revenues & Volume, By Others, 2021- 2031F

6.4 Australia Temporal Arteritis Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Australia Temporal Arteritis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 Australia Temporal Arteritis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.4.4 Australia Temporal Arteritis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7 Australia Temporal Arteritis Market Import-Export Trade Statistics

7.1 Australia Temporal Arteritis Market Export to Major Countries

7.2 Australia Temporal Arteritis Market Imports from Major Countries

8 Australia Temporal Arteritis Market Key Performance Indicators

9 Australia Temporal Arteritis Market - Opportunity Assessment

9.1 Australia Temporal Arteritis Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.2 Australia Temporal Arteritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Australia Temporal Arteritis Market Opportunity Assessment, By End User, 2021 & 2031F

9.4 Australia Temporal Arteritis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 Australia Temporal Arteritis Market - Competitive Landscape

10.1 Australia Temporal Arteritis Market Revenue Share, By Companies, 2024

10.2 Australia Temporal Arteritis Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All